Skip to Main Content

Paper Details

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
3
2023
COVID-19, SARS-CoV-2, casirivimab, imdevimab, mRNA, nAb
Author NameAffiliation
David C MontefioriDuke University Medical Center
Nicole A Doria-RoseVaccine Research Center, National Institutes of Health
  • 1 - 2

Datasets

Release 1.2